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Summary
Since a dysregulated synthesis of tumor necrosis factor a (TNF-a) may be involved in the
pathogenesis of autoimmune diseases, it was ofinterest to precisely locate the recently reported
Ncol restriction fragment length polymorphism (RFLP) of the TNF-a region. However, by
mapping of 56.8 kb of overlapping cosmid clones and direct sequencing, we could localize the
polymorphic Ncol restriction site within the first intron of the TNF-0 gene and not in the
TNF-a gene. To study whether regulatory mechanisms are affected by this polymorphism, we
analyzed the TNF-a/TNF-0 production of phytohemagglutinin-stimuated peripheral blood
mononuclear cells ofindividuals homozygousfor the TNF-0 Ncol RFLP by ELISA and concomitant
Northern blot analysis. On days 2-4 after stimulation with mitogen, the TNFB*1 allele
corresponding to a 5.3-kb Ncol fragment presented with a significantly higher TNF-0 response.
A mRNA analysis demonstrated that higher protein levels of TNF-0 correlate also with increased
amounts ofTNF-0 transcripts. No allelic association was found in respect to TNF-a production.
To further investigate a possible allelic influence on transcription, we determined the DNA sequence
of 2 kb ofthe 5' portion of our cloned TNFB*2 allele and compared it with the available TNF-0
sequences. By computer-aided recognition motifsearch ofDNA binding factors, we report putative
binding sites conserved between mouse and man in the 5' flanking region as well as in intron
1 ofthe TNF-0 gene, found also in other cytokine promoter sequences. In addition, by polymerase
chain reaction amplification and sequencing of 740 by of the 5' part of TNF-0 of individuals
typedhomozygously for the Ncol RFLP, we couldshow that amino acid position 26 is conserved
as asparagine in the TNFB*1 and as threonine in the TNFB* 2 sequence. A previously reported,
EcoRI RFLP in the 3' untranslated region of TNF-0 does not segregate with either of the two
alleles. Thus, four TNFB alleles can de defined at the DNA level.
T
umor necrosis factor a (TNF-a) (cachectin) and TNF-fl
(lymphotoxin) are cytokines with numerous similar im-
munoregulatory effects binding to their target cells via cell
surface receptor molecule types A and'Bwith different affinities
(see references 1-6). The tumoricidal and tumorstatic effects
of TNF-a and TNF-0 raised much interest and led to the
rapid cloning of the genes in mouse and man, as well as to
the production of rTNF-a and rTNF-# (7-10). The broadest
range ofbioactivities has been described for TNF-a (see for
reviews references 1-3), including activation of the transcrip-
tion factor NF-kB (11, 12, 12a). The two cytokines are both
produced by different activated PBMC. While TNF-0 ap-
pears to be mainly produced by stimulated T cells, TNF-a
is the product of activated macrophages, as well as of T, B,
and NK cells (see references 13-15). The localization of the
TNF genes in tandem, within the MHC between HLA-B
and the HLA class III genes (16-19), has raised the suspicion
that the TNF loci might play a role in the notable associa-
tion between HLA and various autoimmune diseases. In a
mouse model for SLE nephritis, both a decreased TNF-a
production, and a RFLP have been correlated with the de-
velopment of the disease (20) . However, the linkage of a de-
creased TNF-a synthesis with a mutation in the TNF-a locus
has been questioned on the basis of RFLP analysis in a large
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presumptive autoimmune TNF-ca allele to be present in many
mouse strains (21) . The search for a possible involvement of
TNF-a in human autoimmunity ledto thedetection ofpoly-
morphismsin thehumanTNFgenes. Several groups described
a Ncol RFLP for the TNF-a gene with the less frequent
allele (5 .5-kbNcoI fragment) beingstrongly linked with the
HLAA1/B8 haplotype (22, 23). The 10.5-kb NcoI allele was
found to be negatively associated with primary biliary cir-
rhosis (24), and heterozygosity for the TNF alleles was
significantly more frequent in patients with type I insulin-
dependent diabetes mellitus (22). In addition, a loss of an
EcoRI recognition sequence of low frequency in the 3' un-
translated region of the TNF-0gene hasbeen described (25).
In this paper, we show that the polymorphicNcol restric-
tion site is located in the first intron of the TNF-0 gene by
mapping overlapping cosmid clones and direct allelic se-
quencing. In addition, the EcoRI RFLP of the 3' untrans-
lated region does not segregate with either Ncol allele, al-
lowing at least four different alleles to be defined by RPLP
typing. We further show that the two TNF-0 alleles also
differ by oneaminoacid at position 26. Functional tests dem-
onstrate that the TNFB"1 allele is strongly associated with
increased TNF-0 production by PBL in response to PHA.
Materials and Methods
Isolation andMappingoftheHuman TNFRegion.
￿
The genomic
DNA from the homozygous B cell line, established from an in-
dividual typed HLA-A3, -Bw47, -Cw6, and-DR7,wasextracted,
andacosmidlibraryin thevector pTCF wasestablished as described
(26). ThehumangenesforTNF-a/owere isolatedby crosshybridi-
zation to amurine TNF-aprobe (kindly provided by Dr. Michael
Steinmetz, Basel, Switzerland) in five overlapping cosmid clones
covering 56.8 kb of genomic DNA and mapped with various re-
striction endonucleases, including NcoI and EcoRI. The restric-
tion map of cosmid cah5 is shown Fig. 2.
Southern Blot Analysis.
￿
Genomic DNA of 70 healthy donors
was analyzed according to standard protocols (27). Thefollowing
DNA probes were used: a TNF-/3 2.4-kb EcoRl, a TNF-ca 2.75-
kb EcoRI, aTNF-0 5' 700-bp BamHI, and a 1.4-kb BamHI frag-
ment. By sequence analysis, thelatter probecarries part ofthehuman
analogue to themurine B144 gene (28), which is located -10kb
centromer of TNF-a. A 2.9-kb Sall/HindlII single copy probe,
located 13 kb upstream of TNF-(3, wasalso used. All probes were
labeled by the random-priming method (29) . Hybridization was
performed with 5 x 106 cpm/ml according to the method of
Church and Gilbert (30). All donors in this studywere typedfor
HLA class I and most also for class II.
The following donors were tested homozygous for the Ncol
5.3-kb TNFB*l allele: BC, A1 B8 Cw7 DR3/4DQw2/w3; BK;
A3/28 B35/w62 Cw3/w4 DRwll; DC; A2 B27/51 Cw2/w3;
FB, Al/2 B8/w62 Cw3/w7;JC, Al/3 B7/51 Cw3/w7 DQwl/3;
KP, A2 B35/w39 Cw4DRw6/w8DQwl/w3; KR, A2 B44Cw5;
LG2, A2 B27 Cwt; SA, Al B8 Cw7 DR3 DQw2; SE, Al/3 B8
Cwt; WW, A2/3 B27/44 Cw2/w5. The following donors were
typedhomozygous forthe 11-kbNcoI fragment (TNFB"2): BCA,
A2/24 B35/w60 C3/w4 DR2/w8 DQwl/w4; BS, A2 B7/13
Cw6/w7 DR7/DQw2; BU; A24/30 B18/w6l Cw2/w5 DR3/5
DQw2/w3; EC, A3/29 B7/44 Cw5/w7 DR2/3 DQwl/2; GB,
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All/24 B27/35 Cwt/w4; GRU, Al/29B7/44DR2/7DQwl/w2;
HP, A2/26Bw62 Cw3; KW, A2/3 Bw60/w62Cw3DR3/4; MG,
A2/11 B7/49 Cw7 DR2/3; MS, All B51/w62 Cw3 DR2/4
DQwl/3; PG, A2/3 B7/w62 Cw3/w7 DR4 DQw3; PH, Al/3
B7/w55 Cw3/w7 DR2/5; PS, A2/32Bw22/44Cw3/w4 DR5/7
DQw2/w3; RK, A3/w33 B7/w64 Cw7 DRS/2 DQwl; RO,
A2/28 B51 DR2/7 DQwl/w2; SD, A2/3 B35/37 Cw4/bl DRI/2
DQwl; SG, A2 B49/w62 Cw4 DR4; SM, Al/2 B27/49 Cw2
DR2/5; SU, A24/32 B18 Cw3 DR2/4 DQwl/w3; WE, A2/30
B13/w62 Cw3/w6 DR2/4.
PCRAmplification ofGenomic DNA.
￿
GenomicDNA was ex-
tracted from PBL, and amplification of TNFgene regions (see for
lower bars in Fig. 2) was performed as described by Saiki et al.
(31), usingtheHybaid thermocycler (Biometra, G6ttingen, FRG).
30 cycles encompassing 1 min ofdenaturation, annealing, and ex-
tension were run. Theinitial denaturation time was 6min. Specific
oligonucleotide primers for the Ncol/amino acid 26 reaction are
depicted in Fig. 3, annealing temperature was 55°C. All oligonu-
cleotides were synthesized by thephosphoramidite method using
a DNA synthesizer (Applied Biosystems, Inc., Foster City, CA)
andused directly afterdeprotection. Foramplification of theEcoRI
polymorphic region, a5' primer (TCCTCAGCCCTAGTACTGTC)
andthesequence CCTGCAGGTGGACAAGACC as 3' primer were
chosen; the annealing temperature was 59°C. Fordirect genomic
DNAsequencing of the5' flanking TNF-aregion, 312by ofDNA
were amplified by priming with the oligonucleotides CAGCAT-
TATGAGTCTCCGGGTC and CTAACTTCCAGACAGGATGC
(annealing temperature 57°C). 1.6 U of Taq-polymerase (United
States Biochemical Corp., Cleveland, OH) were used perreaction.
The amplificationproducts were directly digested either with Ncol
or EcoRI and analyzed on 1.5% agarose gels. In all amplification
experiments, DNAof thehomozygous Bcell line CAHfrom which
thecosmid cah5 hasbeen isolated wasincubatedas internal control.
DNASequence Analysis.
￿
Single-stranded M13 subclones, as well
as double-stranded pUCsubclones, were sequencedby thedideoxy
chain termination method described by Sanger et al. (32), using
either a T7 sequencing kit (Pharmacia Fine Chemicals, Freiburg,
FRG) or the Tag-Track method (Promega Biotec, Madison, WI).
The PCR-amplified DNA products were purified by agarose gel
electrophoresis and phenol/chloroform extraction and sequenced
as described for thesubclones. No differences were foundbetween
sequences determined from the isolated cosmid cah5 or those ob-
tained from amplificate ofgenomicCAHDNA. The denaturation
step wasperformed at 96°C for5min and theannealingprocedure
was shortened to 10 min at 37°C.
Stimulation of TLymphocytes.
￿
PBMC were separatedfrom hep-
arinized venous bloodon aFicoll-Hypaque density gradient (Phar-
macia Fine Chemicals). PBMC were kept in RPMI 1640 sup-
plementedwith 2% L-glutamine, 1% penicillin/streptomycin (both
from GibcoLaboratories, GrandIslands, NY). For analysis oflym-
phokines, 2 x 106cells were stimulated by 2fcg/ml PHA (Sigma
Chemical Co., Deisen-hofen, FRG) and harvested after 1, 2, 3,
or 4 d. All supernatants were centrifuged and frozen immediately
at -80°C.Controlexperiments with unstimulated cells were always
performed in parallel.
Quantitation of TNFa and TNF-0 Protein Titer.
￿
TNF-a and
-(3 were measured by a sandwich ELISA in polystyrene microtiter
plates (FlowLaboratories, Meckenheim, FRG), coated with anti-
TNF-ae mAb 199-1 or antiTNF-0 mAb9B9, respectively (5 wg/ml
in sodium bicarbonate buffer at pH 9.5). The plates were blocked
with 1% BSA (Sigma Chemical Co.). 100 pl of a serially diluted
test sample or recombinant lymphokines at various concentrations
as external standards were added to each well and incubated over-
Structural and Regulatory Polymorphism of Human Tumor Necrosis Factor 0night . Bound lymphokine was detected by biotinylated antiTNF-a
mAb 195-8 or biotinylated polyclonal antiTNF-a antiserum, fol-
lowed by incubation with streptavidin coupled to horseradish per-
oxidase (both from Boehringer Mannheim Biochemicals, Mann-
heim, FRG) . Tetramethylbenzidine (Serva, Heidelberg, FRG) in
acetic acid buffer (pH 4.9) was used as chromogenic substrate. Ex-
tinctions were read in an ELISA spectrophotometer (SIT, Gr6dig,
Austria) at 450nm and were evaluated using a four-parameter anal-
ysis . rTNF-a and rTNF-0, as well as the mAbs 199-1, 195-8, and
9b9 and the polyclonal antiTNF-0 antiserum, were kindly provided
by Dr. A . M8ller (BASF AG, Ludwigshafen, FRG) . The sensitivity
of the ELISA was 10 pg/ml for each lymphokine.
RNA Isolation and Northern Blot Analysis.
￿
RNA was isolated
by the method of Chirgwin et al . (33). To quantitate the TNF
response upon PHA stimulation ofPBMC, theTNF protein levels
after the indicated time were measured in the culture supernatants.
For RNA isolation, 8 x 106 cells were harvested from a parallel
stimulation experiment, started simultaneously but treated for 3 h
with 10,ug/ml ofcycloheximide (Sigma Chemical Co.) before har-
vesting. Totally lysed cells in the extraction buffer were sonified
for 5 s to achieve breakage of the DNA with a cell disruptor with
microtip (B15 ; Branson Sonic Power Co., Danbury, CT), and the
RNA was prepared by CsCl gradient centrifugation . Total RNA
of 6-8 x 106 cells was fractionated by formaldehyde/agarose gel
electrophoresis and blotted to Hybond-N membranes (Amersham,
Braunschweig, FRG) . As specific probe for TNF-a, a genomic
625-bp Xhol/HindIII fragment coding for exon 4/3' untranslated
region was used. The 600-bp Pvull/PstI TNF-/3-specific probe was
prepared of the corresponding TNF-O region . All DNA probes
were labeled and hybridized as described above. The Northern blots
were completely stripped off of the probe by incubation for 1-2 h
at 65°C in 0.1% Denhart's, 5 mM Tris-HCI, and 2mM EDTA,
and rehybridized after blank exposure .
Results
The Polymorphic NcoI Recognition Sequence Is Located in the
First Intron ofthe TNF-0 Gene . We analyzed genomicDNA
from a panel of 70 healthy unrelated individuals for the pres-
ence of a polymorphic Ncol restriction site. Hybridization
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with a genomic 2.4-kb EcoRI TNF-(3 probe (see Fig . 1) de-
tected a 5 .3-kb band in addition to the 11- and 5.7-kb Ncol
fragments hybridizing to the 2.75-kb EcoRl TNF-ca probe .
This result indicated that the polymorphic Ncol recognition
sequence is located within the TNF-(3 gene. Inspection of
the published sequences for the human TNF-a and TNF-O
genes showed the presence ofone Ncol restriction site in the
3' untranslated region ofTNF-a (34, 35) and another one
in the first intron of TNF-0 (34), resulting in the 5.7-kb
TNF Ncol fragment, detected on the Southern blots . To
confirm the location of the polymorphic Ncol site in TNF-/3,
we constructed a Ncol restriction map of the TNF region
(Fig. 2) . Cosmid cah5, containing the 11-kb Ncol TNF re-
gion fragment, was isolated from a genomic cosmid library
derived from the homozygous B cell line CAH (HLA-A3,
-Bw47, -Cw6, -DR7), homozygous for the TNF 11-kb Ncol
fragment (see Fig. 1) . The restriction map shows that the
Ncol site in the first intron of the TNF-0 gene is missing
in DNA containing the 11-kb Ncol TNF allele . We won-
dered whether the two TNF-0 alleles (the 5.7/5.3-kb Nco1
fragments are indicative for the allele further on TNFB"1,
and the 11-kb Ncol fragment corresponds with the presence
of the TNFB"2 allele) only differ by the polymorphic Ncol
restriction site or whether additional mutations are present
within the coding region or in regulatory sequences . We there-
fore determined 2kb ofDNA sequence in the 5' gene region
spanning the polymorphic NcoI site . By sequence compar-
ison to the TNFB"1 sequence (34), another base substitu-
tion is present in intron 1, besides the G to A mutation in
the Ncol recognition sequence, and a third base exchange
results in an amino acid substitution (amino acid 26 : AAC
= Asn to ACC = Thr for TNFB"2) (Fig . 3, boxes) . To define
additional allelic differences, we performed both Southern blot
analysis and/or PCR amplification of 16 TNFB`1 and 16
TNFB"2 homozygous alleles, respectively, using the restric-
tion enzyme EcoRl (see Fig. 2), as a previously reported poly-
morphism in the 3' untranslated region was described with
a frequency of6% (25) . No homozygous 2.5-kb EcoRI sub-
Figure 1 . Genomic Southern blot
analysis of the Ncol polymorphism in
theTNF locus . GenomicDNA isolated
of various cell lines (lurkat, Hut 78,
CAH) and ofPBL of 16 individuals was
digested with Ncol, and 10 kg ofeach
digest was separated on a 0.7% agarose
gel, transferred to nylon membrane, and
sequentially hybridized to the 2.75-kb
EcoRl fragment oftheTNF-a gene and
the 2.4-kb TNF-0 EcoRl fragment (see
Fig. 2) . Closed arrows on the right in-
dicate the Ncol bands detected with the
TNF-a probe, whereas the TNF-0
probe hybridized to the 5 .3-, 5.7-, and
11-kb Ncol fiagments. Molecularweights
in kilobases on the left are given in the
sizes as obtained from the isolated cah5
cosmid .2kb
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type was found, only one heterozygous individual (HLA-
A2, -Bw60/-w62, -Cw3, -DR3/4) out of 32 with the 2.4-
kb EcoRI fragments was detected. The further use of the
B144 and 2.9-kb SaII/HindIII DNA probes (described in
Materials and Methods), both in close vicinity to the TNF
locus, did not detect any RFLP in the DNA of 40 individ-
uals investigated.
The Polymorphic NcoI Site Is Linked with an Amino Acid
Substitution at Position 26. Several TNF-0 sequences (pro-
tein, cDNA, and genomic) have been published that either
code for AAC = Asn (10, 34, 36) or contain in exchange
ACC = Thr at amino acid position 26 (9, 35, 36). We won-
dered whether the NcoI RFLP is linked with the presence
of AAC at amino acid position 26. We therefore amplified
740 by of genomic DNA from exon 1 to intron 3 encom-
passing the polymorphic NcoI site and the variant triplett
coding for amino acid 26 . Amplified genomic DNA of nine
individuals and one amplificate of a gorilla, each homozy-
gous for the 11-kb band, and five human DNAs homozy-
gous for the 5.7/5.3-kb NcoI fragments, were directly se-
quenced. In all cases, the CCATGG (NcoI) sequence and the
additional substitution G at position 368 correlated with the
triplett AAC, and CCATGA with C at position 368 and ACC
(Fig. 3, boxes). Furthermore, heterozygous DNA as amplifi-
cation/sequencing control showed both bases. This result
demonstrates the existence of two TNF-0 protein variants
and that the NcoI RFLP is indicative for this polymorphism
in the TNF-0 protein. Thus, two allelic formsfor the TNF-0
gene are found at the protein level and four alleles can be
detected at the DNA level (NcoI and EcoRl RFLP). Further
sequence comparison with the genomic DNA sequence
reported for the TNFB '1 allele (34), and the partial sequence
described by Nedospasov et al. (35) derived from a TNFB"2
allele, resulted in two additional nucleotides, not found in
our cah5 sequence (Fig. 3, arrows), besides the three allelic
nucleotide changes discussed above (Fig. 3, boxes). The TagI
restriction site, reported by both authors following the EcoRI
Figure 2.
￿
Structure ofthe TNF locus
isolatedin cosmid cah5. Therestriction
map of cosmid cah5 in its centromer
to telomer orientation in the HLA com-
plex is shown on the top line, and an
extended map of the TNF locus is
presented below. The exons oftheTNF-a
H B NSB
￿
(TNFA) and the TNF-0 (TNFB) genes
1- Ld ca h 5
￿
are indicated as closed boxes with the
numbering above. Arrows underneath
mark the orientation and the extent of
the DNA sequencing. The bars at the
bottom show the fragments that have
been PCR amplified from genomic
DNA. The following restriction sites
are indicated: B, BarnHI; E, EcoRl; H,
HindIII; N, NcoI; S, Sall (X, Xhol,
only shown for the extended TNF
locus). The filled triangle marks the
polymorphic NcoI site in intron 1,
which is absent in the TNF-0 gene of
the cah5 allele (TNFB'2).
5' site (deletion of C in position -808; Fig. 3, arrow) is not
present in the cah5 TNFB"2 allele. We analyzed DNA of
38 unrelated individuals for the presence of this 5' flanking
Tagl site by genomic Southern blot analysis and hybridiza-
tion with the 2.4-kb EcoRI TNF-/3 gene fragment and the
5' 700-bp BamHI probe. We only detected the TagI frag-
ments corresponding to the cah5 TNFB"2 allele (data not
shown). Only one substitution has not been redetermined
for both TNFB alleles. Interestingly, this A instead of the
G at -626 is within a putative TPAresponsive DNA element
(TRE)t sequence in the cah5 TNFB"2 allele, with high
affinity for the group of inducible nuclear factors AP-1/c-
fos/jun, and probably would change the binding affinity.
Analysis ofPutative Regulatory Elements ofthe TNF-0 Gene.
We analyzed the TNFB and TNFA promoter regions for the
presence of known nuclear factor binding motifs. In Fig. 3,
we marked the DNA sequences that either have been shown
to bind transcription factors, or that have been shown in other
studies to be of high affinity, some of which are conserved
in the TNF-0 genesbetween man and mouse (37, 38). The
TNFB-kB motiflocated at -95 bp, which binds NF-kB with
high affinity (Messer, G., manuscript submitted for publica-
tion), and the TATA box as well as a SP-1 factor binding se-
quence in between, are exactly conserved in sequence and po-
sition in mouse and man. A potential NF-kB binding site
is present at position -1030 bp, which is located -935 by
upstream of the high affinity -95-bp NF-kB motif. By gel
shift competition assays (data not shown), we could demon-
strate that this sequence binds NF-kB with 10-fold lower
affinity than the -95 kB element, but with higher affinity
than the kB binding site found functional in the IIr2 pro-
moter (39). The significance of the -1,030-kb NF-kB binding
site is not clear yet, as this sequence is contained within the
Alu repeat, and it has not been demonstrated so far that single
'Abbreviation used in this paper: TRE, TPA-responsive DNA element.
Structural and Regulatory Polymorphism of Human Tumor Necrosis Factor /3-1220
(t)15gagacagagtcttgctctgtcccccaggctggaatacagtggtgcgatcttgactcactgcagcctccgcctcccaggttcaaataattctccagcctcagcctcccgagtagct
NF- KB
gggactgcagatgcgcaccagcacgcctggctaatttttgtatttattategagat imt 2c :66Catgttggccagctggtctcaaactcctgacctcaagtaatccgcccacctcag
-970
￿
F Alu
actcccaaagtgccaggattacaggtgtgagccactgcaccaggcctggaacaattttaaaataatgtattggctctgcaaatgcagcttcagaacaagtcccttagctgtccccacccc
accctaagtcaccacccttaagcctcacccatgtggaattctgaaacttcctttgtagaaaactttggaaggtgtctgccacattgatcctggaatgtgtgtttatttggggttatataa
-730
￿
T
￿
THE
atctgttctgtggaagccacctgaagtcaggaagagatggagggcatccttcaggagtgagatgagacctcatcatacttgactgtccagcatcatctctgagt87ggggaccaaaaaat
g
ttatcttccaeactaggacactttcaagagtggaagggggatccattaetattttcacctggacaagaggcaaacaccagaatgtccccgatgaaggggatatataatggaccttcttga
-490
tgtgaaacctgccagatgggctggaaagtccgtetactgggacaagtatgatttgagttgtttgggacaaggacoggggtacaagagaaggaaatgggcaaagagagaagcctgtactca
gccaagggtgcagagatgttatatatgattgctcttcagggaaccgggcctccagctcacaccccagctgctcaaccacctcctctctgaattgactgtcccttctttggaactctaggc
-250
ctgaccccactccctggccctcccagcccacgattcccctgacccgactccctttcccagaactcagtcgcctgaacccccegcctgtggttctctcctaggcctcagcctttcctgcct
THE
￿
NF-KB
￿
SP-1
ttgactgaaacagcagtatcttctaagccct t aggccccagccccgacctagaacccgcccgctgcctgccacgctgccactgccgcttcctct~tMgggacctgag
- 10 +1
￿
SP.-1...
cgtccgggccCAGGGGCTCCGCACAGCAGGTGAGGCTCTCCTGCCCCATCTCCTTGGGCTGCCCGTGCTTCGTGCTTTGGACTACGdtttAGCAGTGTCCTGCCCTCTGCCTGGGCCTCG
THE THE
GTCCCTCCTGCACCTGCTGCCTGGATCCCCGGCCTGCCTGGGCCTGGGCTTGgtgggtttggttttggtttccttctctgtctctgectctccatctgtcagtctcattgtctctgtcac
+231
acattctctgtttctg catga tcctctctgttcccttcctgtctctctctgtctccctctgctcaccttggggtttctctgactgcatcttgtccccttctctgtcgatctctctctc
9
SP-1
￿
SP-1
￿
met thr pro
gggggtcggggggtgct ctcccagggC"gaggtctgtcttccgccgcgtgccttgccccgctcactgtctctctctctctctctctttctctgcagGTTCTCCCC ATG ACA CCA
pro glu erg leu phe Leu pro arg vat cys gly thr thr leu his Leu leu Leu Leu gly leu leu Leu vat leu Leu pro gly ale gln
CCT GAA CGT CTC TTC CTC CCA AGG GTG TGT GGC ACC ACC CTA CAC CTC CTC CTT CTG GGG CTG CTG CTG GTT CTG CTG CCT GGG GCC CAG
+558
￿
gly Leu Pro Gly Vat Gly Leu Thr
gtgaggcagcaggagaatgggggctgctggggtggctcagccaaaccttgagccctagagcccccctcaactctgttctcccctag GGG CTC CCT GGT GTT GGC CTC ACA
Pro Ser Ala Ala Gln Thr Ala Arg Gln His Pro Lys Met His Leu Ale His Ser Thr Leu Lys Pro Ala Ala His Leu lie g
CCT TCA GCT GCC CAG ACT GCC CGT CAG CAC CCC AAG ATG CAT CTT GCC CAC AGC ACC CTC AAA CCT GCT GCT CAC CTC ATT'G gtaaacatcc
A
Asn +792
aCCLgBCCLCCC898C8t9tCCCC8CC89CYCL
NF-kB sites separated by such a distance can strongly cooperate
in stimulation of transcription (40) . A putative AP-2 recog-
nition motifoverlapping the 5' half-site of the -95-bp TNFB-kB
site is also found in the mouse sequence (38; EMBL/Gen-
Bank corrected version, accession number Y00467). Further-
more, two putative THE sequences in position -626 and -126
are positioned upstream of the -95-bp NF-kB site and were
reported to be high affinity motifs of the H-ras gene and the
murine IL-2 gene for TPA inducibility (41, 42). The -126
THE site has the same sequence consensus and is in the ap-
proximal position as the THE found to confer IIr1 induc-
ibility in the 11,2 promoter (43). Interestingly, the preposi-
tioned intron 1 of the TNF-fl gene, spliced out of the 5'
untranslated region, also contains two additional THE binding
sites, one THE site is a homologue of the c:fos/jun respon-
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Figure 3.
￿
The 5' sequence of the humanTNF-0 gene (TNFB'2), derived from cah5. The nucleotide sequence of the exons is given in capital letters
to distinguish it from 5' flanking andintronic nucleotides numbered in relation to the transcription start site (+1) (9, 10). The protein coding DNA
sequence is presented in triplets with the amino acids displayed above and the sequence of the mature TNF-0 polypeptide in capital letters. The amino
acid substitution in the TNFB'1 sequence is shown below the variant triplet. Thethree nucleotide changes in the TNFB'1 allele, including the resulting
NcoI recognition sequence and the variant amino acid at position 26, are boxed. The NF-kB binding sites, the TATA box, and the two sequences
used as oligonucleotides for PCRamplification are underlined. The 3' border ofthe Alurepetitive element in the 5' flanking region is marked. Nucleo-
tides in which the published TNF-0 genomic sequences (34, 35) differ from the cah5 sequence, but which have been confirmed by restriction enzyme
digestion or PCR amplification and direct sequencing of several TNFB'1 and TNFB'2 alleles to be identical to the cloned cah5 gene, are indicated
by an arrow. Onedifference in position -626 wasnot checked in our amplification/sequencing protocol andis shown as such below the cah5 nucleotides.
DNA sequence motifs for the interaction with transcription factors are highlighted by stippling. Only those sites are shown that either have been
shown by us (NF-kB sites) or in other systems to bind the corresponding nuclear factors with high affinity, or that are conserved in sequence and
location in the TNF-0 gene of the mouse (5' AP-1, NF-kB site -95 bp, SPl elements -65 and +410 bp, and the TATA box) (37, 38).
sive element of the ras oncogene and a reverse homologue
to the murine IIr2 gene -150 TREp element (41, 42). Both
motifs have been shown to act alone as strong inducible ele-
ments for TPA induction. Here they might cooperate synergis-
tically due to their head-to-head orientation with three-base
spacing as an imperfect palindromic motiffor two AP-1 mol-
ecules, shown to increase the affinity up to 60-fold (44) . The
THE elements of the TNF-0 gene described above all seem
to bind the AP-1, jun, cfos heterodimer transcription factor
family, and do not agree with the character of the related
CRE/cAMP-responsive element (45). No CRE binding motif
in TNF-0 was found, whereas one has been reported for the
TNF-cx promoter in position -105 by (46). The first intron
also has a strong binding potential, conserved in mouse, pri-
mates, and man, for the constitutively expressed transcrip--687
CAGCATTATG AGTCTCCGGG TCAGAATGAA AGAAGAGGGC
-597
GGTGATTTCA CTCCCCGGGG CTGTCCCAGG CTTGTCCCTG
AAA A A A
AAGCCTGCCA CCAAGCCCCC AGCTCCTTCT CCCCGCAGGG
-444
CTTTTCCCTC CAACCCCGTT TTCTCTCCCT CAAGGACTCA
T
TATCTTTTTC CTGCATCCTG TCTGGAAGTT AGAAGGAAA
tion factor SP1, and the SP1 motif close to the 3' splice site
of intron 1 has the highest binding activity reported for
SP1 (47).
Analysis ofthe TNF-a S' PromoterRegion Linked to the Ncoi
RFLP. As the Ncol RFLP in intron 1 of the TNF-(3 gene
might also be linked to variations in the proximate, down-
stream localized TNFA, we compared the genomic sequences
of the TNF-a gene that have been published together with
the corresponding TNFB*1 (34) and TNFB'2 (35) alleles,
though homozygosity in respect of the NcoI RFLP of the
A
CTGCCCCAGT
CTACCCGCAC
CCCAAACACA
GCTTTCTGAA
DNA used for library construction cannot be presumed. No
difference has been reported for the amino acid sequence of
the genomic TNF-a clones, but intriguingly, a cluster of 10
nucleotide differences is found between the two sequences
(Fig. 4) (35) within a 160-bp long G/C-rich region of the
TNF-a 5' flank. The corresponding region in the mouse
TNF-a gene was shown to regulate the stimulation ofTNF-a
productionby LPS (48, 49). Although we did not detect any
differences in TNF-a production upon stimulation ofPBMC
with PHA between individuals varying in the TNF-NcoI-
GGGGTCTGTG AATTCCCGGG
AAA
Figure4.
￿
Partial 5' TNF-apromoter
region determined from cosmid cah5.
The 312-bp fragment of the TNF-a
promoter region (-687 to -370), corre-
sponding to nucleotides 3411-3723 of
the TNF region published by Nedo-
spasov et al. (35), was amplified from
genomic DNA using the following
oligonucleotide pair (5' primer:
CAGCATTATGAGTCTCCGGGTC;
3' primer: CTAACTTCCAGACAG-
GATGC) and sequenced directly by
priming with the same oligomers. Tri-
angles indicate nucleotides missing in
the TNF-apromoter sequence reported
by Nedwin et al. (34). Thearrow indi
GCCCCTCCCA GTTCTAGTTC
￿
cates a C that is present in the other
sequences (34, 35), and the dot marks
the position where Nedwin et al. (34)
reported an A.
-627
CCAGCCTTTC CTGAGGCCTC
GGCCTCAGGA CTCAACACAG
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Figure 5.
￿
TNFprotein production after PHA stimulation ofPBMC ofindividuals matched for the NcoI polymorphism of the TNF-(3 gene. Compar-
ison of donors homozygously typed for the TNFB'1 (5.3-kb fragment;filledarrowheads) andTNFB*2 (11-kb fragment; open arrowheads) alleles in regard
to TNF protein production ([a] TNF-/3 and [b] TNF-a production) upon PHA stimulation of PBMC. Each symbol represents one individual, tested
two to three times. Dueto paucity of cells, not every subject could be measured at every point. In the stimulation of 2 x 106 cells with 2 wg/ PHA,
supernatants were harvested after 1, 2, 3, and 4d. The protein levels were assayed by a TNF-(3- or TNT-a-specific ELISA and are shown in picograms
per milliliter. p values were determined by the Mann Whitney test.
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day 1 day 2 day 3 day 4 day 1 day 2 day 3 day 4RFLP, we tested the possibility that TNF-ci alleles might
differ significantly in their promoter sequence by PCR am-
plification and direct sequencing of the TNF-ci 5' region of
five individuals each homozygous for either TNFB"1 or
TNFB'2, and in addition, we determined the sequence of
the corresponding segment of clone cah5 (see Fig. 4) . Se-
quences of the amplified fragments run in parallel did not
detect any differences between the 10 different amplified
TNF-cx promoter regions (including twoA1/B8 haplotypes),
which were identical to the sequence obtained from the cah5
TNF-a fragment .
The TNFB"1 Allele Leads to a Higher TNRO Response upon
PHA Stimulation ofTLymphocytes. To investigate both Ncol-
defined alleles for functional differences inTNF-0 and TNF-cx
gene expression, PBMC from healthy individuals homozy-
gous for the 11-kb Ncoi fragment (n = 11) or the 5.3-kb
Ncol fragment (n = 9) were stimulated with mitogen (PHA)
to activateTNF production . TNF-ci and TNF-0 protein levels
were determined by ELISA on days 1, 2, 3, and 4 . Due to
paucity of cells, TNF-ci and -a could not be measured on
all days for each individual . Despite great interindividual vari-
ation inTNF-0 production, mean TNF-# levels were higher
in TNFB"1 homozygous subjects on all days (Fig. 5 a) . These
differences were statistically significant on day 2 (TNFB"1,
7.6 ± 3.0 ng/ml; TNFB"2, 0.5 ± 0.4 ng/ml; p-0.021), on
day 3 (TNFB"1, 5.2 ± 1.6 ng/ml; TNFB"2,1.5 ± 0.6 ng/ml;
p = 0.0257), and on day 4 (TNFB"1, 4.7 ± 0.9 ng/ml;
TNFB"2, 1.4 ± 1.0 ng/ml ; p = 0.0306), when analyzed
by the Mann Whitney test. The TNF-0 responses were a
stable feature of the individuals, as repeating the experiments
after varying time intervals resulted in the same phenotype .
High responders always showed an elevated TNF-0 produc-
tion and low responders gave a reduced TNF-0 response. In
both groups ofhomozygous individuals, TNF-0 titer in cul-
ture supernatants upon PHA stimulation correlate with the
level ofTNF-0 transcripts of the concomittantly performed
TNF-0mRNA analysis (Fig . 6, a and b) . TheTNF-0 mRNA
signals were stronger in the TNFB'1 group. In contrast to
TNF-a, no statistically significant difference in TNF-cx pro-
tein (Fig. 5 b) or mRNA levels between the two groups was
assessed (data not shown) .
Discussion
The TNF NcoI polymorphism, previously thought to be
present within the TNF-ci gene, has been analyzed by sev-
Figure 6 .
￿
Northern blot analysis ofRNA isolated from control cell lines andPBMC upon stimulation. Total RNA was isolated from the cell lines
SW480 and Hut 78 and Jurkat cells after stimulation with PHA/TPA . To amplify the TNF-S mRNA level, cycloheximide (CHX) (10 gg/ml) was
added to some cultures 3 h before harvesting (compare 5-h stimulation ofJurkat cells with and without CHX) . CHX treatment only increased the
TNF-a and TNF-j6 mRNA signals, but did not change the relative character of the inducibility. Hut 78 expresses TNF-0 constitutively and SW
480 was included as negative control . The result of the hybridization with the TNF-,B probe is shown above the ethidium bromide staining of the
28S ribosomal RNA included as control for the amount of RNA loaded on the gels. (a) PBMC of two individuals homozygous for the 5.3/5.7-kb
TNF-0 Ncol fragments (8 x 106 ofWW. and 6 x 106 ofM.W) were stimulated with PHA, and RNA was analyzed after the intervals indicated .
The weaker signals in the stimulation ofPMBC ofM.W. is due to less RNA applied on the gel (see ethidium bromide staining of the 28S RNA) .
(b) 8 x 106 PBMC of individuals WE . and M.G. (homozygous for the 11-kb TNF-0 Ncol fragment) were stimulated and mRNA analysis was per-
formed as described . As WE . and M.G . stimulations were tested on a separate gel, the positive (Hut 78) and the negative (SW 480) controls are
shown again on the right side to demonstrate that this hybridization was exposed longer than the Jurkat/Hut 78/SW 480 control on the left and
the Northern blot in a (see a stronger TNF-0 signal in the Hut 78 lane on the left) .
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Messer et al.eral groups. Its less frequent allele, as definedbelow (TNFB"1,
p = 0.06-0.1), was shown to be strongly associated with
the HLAA1, -B8, -DR3 haplotype (22-24), well known for
its close association with various autoimmune diseases such
as SLE, IDDM, celiac disease, myasthenia gravis, and rheu-
matoid arthritis (50). In this report, we show that the NcoI
RFLP reported for TNF-a is instead located in the first in-
tron of the TNF-/3 gene. Moreover, the described substitu-
tion is linked with two additional exchanges in TNFB, one
present in the first intron and the otherleading to an amino
acid substitution at position 26. Thus, we can define two
TNF-O alleles: TNFB"1 containing the Ncol restriction site
and AAC at position 26, and TNFB"2 for the gene lacking
the Ncol restriction site and coding for ACC.
The functional determinants of the TNF-a and TNF-a
molecules have not been well characterized so far. It was shown
that the COON terminus is essential for cytotoxic activity
(3). TNF-a, and presumably TNF-Q, are described to exert
theirbiological functions as trimers (51), as recently confirmed
by the three-dimensional structure of TNF-a existing as a
trimeric molecule ordered in a (3-barrel jelly-roll configura-
tion (52). Since TNF-(3 has several activities in addition to
its cytotoxicity against sensitive target cells, the biological
significance of the single amino acid substitution cannot be
assessed, unless it has been tested in a variety of functional
assays.
We asked whether the defined alleles might also influence
the production of TNF-a and TNF-O by activated PBMC
isolated from donors homozygous for the TNFB"1 and
TNFB"2 haplotypes. Here, we demonstrate a fivefold higher
secretion of TNF-O by PBMC of TNFB"1 homozygous
donors, while no significant differences in TNF-a titers were
found (although the previously published genomic sequences
would predict significant difference in the inducibility of
TNF-a due to variation in the 5' sequence [34, 35]). The
direct genomic sequencing data reported here revealed no differ-
ences in the promoter region of the TNF-a gene (see Fig.
4), and are concordant with TNF-a protein analysis.
Previously, significant interindividual variations in the level
of TNF-a induction have been described in normal healthy
individuals, which were interpreted as inherited interindividual
differences (53, 54). In addition, high and low responders
were observed with regard to TNF-a production in males,
but no linkage to the Ncol RFLP was found (54), a result
in agreement with our data on the TNF-ci response. Interest-
ingly, a correlation was found between TNF-ci production
and MHC class II genotype, showing a reduced level for
HLA-DR2 (54, 55) and DQwl-positive donors but higher
TNF-a titers in individuals with DR3 and DR4 (54) . The
group of donors analyzed here was selected with regard to
the Ncol RFLP, thus, a correlation with HLA-DR haplo-
type cannot be evaluated. Previous measurements of TNF-O
production in vitro did not detect a correlation of high or
low response patterns to a particular HLA class I or class
II genotype, a result to be expected from our findings, as
the subjects of previous studies had not been matched for
the NcoI RFLP. Thus far, a reproducibly significant differ-
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ence in the induction ofTNF-(3 production was only found
in association with the NcoI RFLP. Due to the distribution
of the two TNFB alleles, only few individuals homozygous
for the TNFB"1 allele couldhave been included in the other
experiments. We did not observe significant differences in
TNF inducibility with regard to the sex in the panel of indi-
viduals tested, a result supported by a previous investigation
of a large collective of healthy donors not matched for the
TNFB genotype.
The TNF protein production is regulated by very com-
plex mechanisms (56-58). We could show that the differ-
ence of the TNFB alleles in the inducibility ofTNF-O is pre-
sumably regulated at the level oftranscription and is not due
to variability in post-translational regulation, or to increased
affinity of the anti TNF-O antibody used in the ELISA to
the TNFB"1 product . The high responders showed an in-
creased level of TNT-0 mRNA already after 4 h of stimula-
tion, whereas no differences were found for the amount of
TNF-a mRNA when comparing the activation results of
PBMC for both TNFB alleles. The result did not change
when we added cycloheximide to the cultures 3 h before har-
vesting. The application of the protein synthesis inhibitor
only resulted in a dramatic increase of the TNF-a and TNF-O
hybridization signals, but did not affect the relative level of
TNF inducibility. Thus, the increased amount of TNF-O
mRNA in stimulated PBMC of individuals homozygous for
the TNFB"1 allele cannot be explained by different mRNA
stability but should be due to higher transcriptional activity.
Moreover, the two TNFB alleles do not differ in the 3' un-
translated region and in the sequences known to influence
mRNA stability (34, 35) .
To find out the transcriptional mechanisms, mediating
TNF-O induction, we inspected the 5' region for sequence
patterns conserved with regard to cell type specificity and
similarity in man and mouse. So far, very little is known about
the regulatory mechanisms that control transcription ofTNFB.
The characterization of one NF-kB/KBF1 binding sequence
motif in a promoter position of the TNF-O gene as a medi-
ator in T cells that is conserved in mouse and man (Messer,
G., manuscript submitted for publication), led us to search
for further protein binding patterns within the two TNF-(3
alleles. We identifiedseveral nuclear factor binding motifs that
should be relevant in the regulation of TNFB transcription
and that are also present in other genesspecifically expressed
in T cells (see Fig. 3). None of the allelic base pair substitu-
tions is present in a known transcription factor recognition
sequence, although the first intron contains such sequences.
Thus, the allelic differences leading to an increased level of
TNF-O mRNA for the TNFB*1 allele upon stimulation might
point to novel regulatory sequence elements.
The TNFB"1 allele is strongly linked to the HLA-Al/-B8
(8.1) haplotype (22-24), and the altered productionofTNF-(3
and the variant polypeptide structure might contribute to
disease susceptibility of this haplotype. In animal models,
agents that regulate TNF productionor activity (3) or appli-
cation of TNF-a (20) can inhibit advancement ofpathogen-
esis of the diseases. The role of TNF-a in the development
Structural and Regulatory Polymorphism of Human Tumor Necrosis Factor 0of chronic autoimmune diseasecouldbe in the local stimula-
tion of class II molecules in costimulation with IFN-y, as
proposed for IDDM, ofhuman pancreatic islet cellsin vitro
(59) . It may also inhibit thefunction ofa cells or contribute
to thecell destruction in this disease. An aberrant localproduc-
tion ofcytokineswas proposed forthe nonobese diabetic mice
model, and it was proposed that a TNF-a and granzyme
A production of intra-islet infiltrating lymphocytes might
possibly play a role in the tissue damage (60).
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